Cargando…
Predicting Anticancer Drug Response With Deep Learning Constrained by Signaling Pathways
Thanks to the availability of multiomics data of individual cancer patients, precision medicine or personalized medicine is becoming a promising treatment for individual cancer patients. However, the association patterns, that is, the mechanism of response (MoR) between large-scale multiomics featur...
Autores principales: | Zhang, Heming, Chen, Yixin, Li, Fuhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581064/ https://www.ncbi.nlm.nih.gov/pubmed/36303766 http://dx.doi.org/10.3389/fbinf.2021.639349 |
Ejemplares similares
-
Opportunities and challenges in interpretable deep learning for drug sensitivity prediction of cancer cells
por: Samal, Bikash Ranjan, et al.
Publicado: (2022) -
DeepRaccess: high-speed RNA accessibility prediction using deep learning
por: Hara, Kaisei, et al.
Publicado: (2023) -
PhosVarDeep: deep-learning based prediction of phospho-variants using sequence information
por: Liu, Xia, et al.
Publicado: (2022) -
Investigating the relevance of major signaling pathways in cancer survival using a biologically meaningful deep learning model
por: Feng, Jiarui, et al.
Publicado: (2021) -
piRNN: deep learning algorithm for piRNA prediction
por: Wang, Kai, et al.
Publicado: (2018)